Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The closing price of Akebia Therapeutics Inc (NASDAQ: AKBA) was $2.16 for the day, up 0.93% from the previous closing price of $2.14. In other words, the price has increased by $0.93 from its previous closing price. On the day, 2.75 million shares were traded.
Ratios:
Our analysis of AKBA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.21 and its Current Ratio is at 1.41.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Jefferies on April 01, 2025, initiated with a Buy rating and assigned the stock a target price of $6.
H.C. Wainwright Upgraded its Neutral to Buy on August 28, 2023, while the target price for the stock was maintained at $3.75.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 03 ’25 when Butler John P. sold 46,409 shares for $1.83 per share. The transaction valued at 84,928 led to the insider holds 2,557,921 shares of the business.
Burke Steven Keith sold 7,144 shares of AKBA for $13,074 on Mar 03 ’25. The SVP, Chief Medical Officer now owns 809,090 shares after completing the transaction at $1.83 per share. On Mar 03 ’25, another insider, Burke Steven Keith, who serves as the Officer of the company, bought 7,144 shares for $1.83 each.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 3.52.
Stock Price History:
Over the past 52 weeks, AKBA has reached a high of $2.89, while it has fallen to a 52-week low of $0.80. The 50-Day Moving Average of the stock is 10.46%, while the 200-Day Moving Average is calculated to be 25.18%.
Shares Statistics:
A total of 261.23M shares are outstanding, with a floating share count of 250.51M. Insiders hold about 4.10% of the company’s shares, while institutions hold 23.96% stake in the company.
